Paper39495243
Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation.
Amoey D and 9 others. Cardiol Ther, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation. Papers, record 39495243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39495243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03192774 | The Prospective Segeberg TAVI Registry | Derived from the trial | Yes |
Source ClinicalTrials.gov
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36769872 | Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain. | J Clin Med | 2023 | https://conductscience.org/library/papers/36769872 | PubMed |
| 2 | 32640949 | Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation. | Stroke | 2020 | https://conductscience.org/library/papers/32640949 | PubMed |
| 3 | 32146898 | Rates of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE-AF Study. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/32146898 | PubMed |
| 4 | 33385355 | Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation. | Am J Cardiol | 2021 | https://conductscience.org/library/papers/33385355 | PubMed |
| 5 | 33895845 | 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. | Europace | 2021 | https://conductscience.org/library/papers/33895845 | PubMed |
| 6 | 34156404 | Transcatheter Treatment of Valvular Heart Disease: A Review. | JAMA | 2021 | https://conductscience.org/library/papers/34156404 | PubMed |
| 7 | 29525891 | A Review of the Role of Non-Vitamin K Oral Anticoagulants in the Acute and Long-Term Treatment of Venous Thromboembolism. | Cardiol Ther | 2018 | https://conductscience.org/library/papers/29525891 | PubMed |
| 8 | 9197854 | Blood transfusion. An independent risk factor for postinjury multiple organ failure. | Arch Surg | 1997 | https://conductscience.org/library/papers/9197854 | PubMed |
| 9 | 30522749 | Recovery of Kidney Dysfunction After Transcatheter Aortic Valve Implantation (from the Northern New England Cardiovascular Disease Study Group). | Am J Cardiol | 2019 | https://conductscience.org/library/papers/30522749 | PubMed |
| 10 | 21639811 | Transcatheter versus surgical aortic-valve replacement in high-risk patients. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21639811 | PubMed |
| 11 | 28798139 | Impact of Non-Vitamin K Antagonist Oral Anticoagulants From a Basic Science Perspective. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28798139 | PubMed |
| 12 | 20037180 | Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. | Eur Heart J | 2010 | https://conductscience.org/library/papers/20037180 | PubMed |
| 13 | 30409498 | A Review of the Efficacy and Safety Profiles of the Novel Oral Anticoagulants in the Treatment and Prevention of Venous Thromboembolism. | Clin Ther | 2018 | https://conductscience.org/library/papers/30409498 | PubMed |
| 14 | 35583186 | Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. | Eur Heart J | 2022 | https://conductscience.org/library/papers/35583186 | PubMed |
| 15 | 23036636 | Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. | J Am Coll Cardiol | 2012 | https://conductscience.org/library/papers/23036636 | PubMed |
| 16 | 30664837 | Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation. | Am J Med | 2019 | https://conductscience.org/library/papers/30664837 | PubMed |
| 17 | 21646060 | Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. | EuroIntervention | 2011 | https://conductscience.org/library/papers/21646060 | PubMed |
| 18 | 16622613 | Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. | J Thromb Thrombolysis | 2006 | https://conductscience.org/library/papers/16622613 | PubMed |
| 19 | 29355169 | Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. | Nat Rev Nephrol | 2018 | https://conductscience.org/library/papers/29355169 | PubMed |
| 20 | 29644411 | NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation. | Clin Res Cardiol | 2018 | https://conductscience.org/library/papers/29644411 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39495243
GET https://conductscience.org/api/papers/v1/39495243/references?page=2